540 related articles for article (PubMed ID: 17469153)
1. Predictors of mortality in adults with cystic fibrosis.
Courtney JM; Bradley J; Mccaughan J; O'Connor TM; Shortt C; Bredin CP; Bradbury I; Elborn JS
Pediatr Pulmonol; 2007 Jun; 42(6):525-32. PubMed ID: 17469153
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome of Burkholderia cepacia complex infection in cystic fibrosis adults.
Courtney JM; Dunbar KE; McDowell A; Moore JE; Warke TJ; Stevenson M; Elborn JS
J Cyst Fibros; 2004 Jun; 3(2):93-8. PubMed ID: 15463892
[TBL] [Abstract][Full Text] [Related]
3. Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis.
Jones AM; Dodd ME; Govan JR; Barcus V; Doherty CJ; Morris J; Webb AK
Thorax; 2004 Nov; 59(11):948-51. PubMed ID: 15516469
[TBL] [Abstract][Full Text] [Related]
4. Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward.
Döring G; Jansen S; Noll H; Grupp H; Frank F; Botzenhart K; Magdorf K; Wahn U
Pediatr Pulmonol; 1996 Feb; 21(2):90-100. PubMed ID: 8882212
[TBL] [Abstract][Full Text] [Related]
5. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance.
De Baets F; Schelstraete P; Van Daele S; Haerynck F; Vaneechoutte M
J Cyst Fibros; 2007 Jan; 6(1):75-8. PubMed ID: 16793350
[TBL] [Abstract][Full Text] [Related]
6. Polymerase chain reaction for the detection of Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia in sputum of patients with cystic fibrosis.
Karpati F; Jonasson J
Mol Cell Probes; 1996 Dec; 10(6):397-403. PubMed ID: 9025076
[TBL] [Abstract][Full Text] [Related]
7. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
[TBL] [Abstract][Full Text] [Related]
8. The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre.
Dobbin C; Maley M; Harkness J; Benn R; Malouf M; Glanville A; Bye P
J Hosp Infect; 2004 Apr; 56(4):277-82. PubMed ID: 15066737
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.
Emerson J; Rosenfeld M; McNamara S; Ramsey B; Gibson RL
Pediatr Pulmonol; 2002 Aug; 34(2):91-100. PubMed ID: 12112774
[TBL] [Abstract][Full Text] [Related]
10. Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis.
Vogelberg C; Hirsch T; Rösen-Wolff A; Kerkmann ML; Leupold W
Pediatr Pulmonol; 2003 Oct; 36(4):348-52. PubMed ID: 12950050
[TBL] [Abstract][Full Text] [Related]
11. Identification of Pseudomonas aeruginosa, Burkholderia cepacia complex, and Stenotrophomonas maltophilia in respiratory samples from cystic fibrosis patients using multiplex PCR.
da Silva Filho LV; Tateno AF; Velloso Lde F; Levi JE; Fernandes S; Bento CN; Rodrigues JC; Ramos SR
Pediatr Pulmonol; 2004 Jun; 37(6):537-47. PubMed ID: 15114555
[TBL] [Abstract][Full Text] [Related]
12. [Isolation frequency of Burkholderia cepacia from cystic fibrosis patients].
Ocak F; Gözalan A; Ozçelik U; Anadol D; Kiper N; Aktepe OC; Göçmen A; Esen B
Mikrobiyol Bul; 2002 Jan; 36(1):1-10. PubMed ID: 12476760
[TBL] [Abstract][Full Text] [Related]
13. Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre.
Ledson MJ; Gallagher MJ; Jackson M; Hart CA; Walshaw MJ
Thorax; 2002 Feb; 57(2):142-5. PubMed ID: 11828044
[TBL] [Abstract][Full Text] [Related]
14. Familial concordance of phenotype and microbial variation among siblings with CF.
Picard E; Aviram M; Yahav Y; Rivlin J; Blau H; Bentur L; Avital A; Villa Y; Schwartz S; Kerem B; Kerem E
Pediatr Pulmonol; 2004 Oct; 38(4):292-7. PubMed ID: 15334505
[TBL] [Abstract][Full Text] [Related]
15. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients.
Hansen CR; Pressler T; Nielsen KG; Jensen PØ; Bjarnsholt T; Høiby N
J Cyst Fibros; 2010 Jan; 9(1):51-8. PubMed ID: 19939747
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa and Burkholderia cenocepacia infections in patients affected by cystic fibrosis: serum resistance and antibody response.
Savoia D; Deplano C; Zucca M
Immunol Invest; 2008; 37(1):19-27. PubMed ID: 18214797
[TBL] [Abstract][Full Text] [Related]
17. Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis.
Kalish LA; Waltz DA; Dovey M; Potter-Bynoe G; McAdam AJ; Lipuma JJ; Gerard C; Goldmann D
Am J Respir Crit Care Med; 2006 Feb; 173(4):421-5. PubMed ID: 16272450
[TBL] [Abstract][Full Text] [Related]
18. The gender gap in cystic fibrosis survival.
Davis PB
J Gend Specif Med; 1999; 2(2):47-51. PubMed ID: 11252861
[TBL] [Abstract][Full Text] [Related]
19. Antibody response to Burkholderia cepacia in patients with cystic fibrosis colonized with Burkholderia cepacia and Pseudomonas aeruginosa.
Hendry J; Butler S; Elborn JS; Govan JR; Nelson J; Shale DJ; Webb AK
J Infect; 2000 Mar; 40(2):164-70. PubMed ID: 10841094
[TBL] [Abstract][Full Text] [Related]
20. Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria.
Hadjiliadis D; Steele MP; Chaparro C; Singer LG; Waddell TK; Hutcheon MA; Davis RD; Tullis DE; Palmer SM; Keshavjee S
J Heart Lung Transplant; 2007 Aug; 26(8):834-8. PubMed ID: 17692788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
